BioWorld

July 12, 2002

View Archived Issues

Serono Enlists Marketing Muscle' Of Pfizer In $200M Rebif Alliance

Serono SA is teaming up with Pfizer Inc. to co-promote the multiple sclerosis drug Rebif in the United States, which will position Rebif directly against Biogen Inc.'s powerhouse drug Avonex. (BioWorld Today) Read More

MedImmune Working Feverishly' On Resolving FluMist Concerns

Read More

Human Equivalent Of Nematode Dog-1 Implicates Mutated Protein In BRCA1 Breast Cancer Tumors

Read More

BioCryst Trims Staff, Changes Focus To Earlier-Stage Programs

Read More

Other News To Note

Read More

Bioethics Council Votes 10-7 For Therapeutic Cloning Moratorium

Read More

Appointments And Advancements

Read More